The DOI matches its Crossref record; 717 of the 717 references it cites were found in a registry or an index.
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
Abstract
The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections. This guidance document focuses on infections caused by extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), AmpC β-lactamase-producing Enterobacterales (AmpC-E), carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR P. aeruginosa), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia. This updated document replaces previous versions of the guidance document. A panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections formulated questions about the treatment of infections caused by ESBL-E, AmpC-E, CRE, DTR P. aeruginosa, CRAB, and S. maltophilia. Because of differences in the epidemiology of AMR and availability of specific anti-infectives internationally, this document focuses on the treatment of AMR infections in the United States. Preferred and alternative suggested treatment approaches are provided with accompanying rationales, assuming the causative organism has been identified and antibiotic susceptibility results are known. Approaches to empiric treatment, transitioning to oral therapy, duration of therapy, and other management considerations are discussed briefly. Suggested approaches apply for both adult and pediatric populations, although suggested antibiotic dosages are provided only for adults. The field of AMR is highly dynamic. Consultation with an infectious diseases specialist is recommended for the treatment of AMR infections. This document is current as of December 31, 2023 and will be updated periodically. The most current version of this document, including date of publication, is available at www.idsociety.org/practice-guideline/amr-guidance/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–717 of 717
Mularoni, A., Mezzatesta, M. L., Pilato, M., Medaglia, A. A., Cervo, A., Bongiorno, D., Aprile, A., Luca, A., Stefani, S., & Grossi, P. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.085 · Cited by 27
ten Doesschate, T., Kuiper, S., van Nieuwkoop, C., Hassing, R. J., Ketels, T., van Mens, S. P., van den Bijllaardt, W., van der Bij, A. K., Geerlings, S. E., Koster, A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab934 · Cited by 27
López-Montesinos, I., Gómez-Zorrilla, S., Palacios-Baena, Z. R., Prim, N., Echeverría-Esnal, D., Gracia, M. P., Montero, M., Durán, X., Sendra, E., Sorlí, L., et al. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00570-z · Cited by 27
Martín‐Loeches, I., Timsit, J., Kollef, M. H., Wunderink, R. G., Shime, N., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Bruno, C. J., Huntington, J. A., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab494 · Cited by 27
Kurpiel, P. M., & Hanson, N. D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr479 · Cited by 26
Carbapenem Susceptibility Discords among Acinetobacter Isolates
Jones, R., Sader, H. S., Fritsche, T. R., & Rhomberg, P. R. (2005) · Clinical Infectious Diseases · doi:10.1086/498754 · Cited by 26
Sénard, O., Lafaurie, M., Lesprit, P., Nguyen, Y., Lescure, F.-X., Therby, A., Fihman, V., Oubaya, N., & Lepeule, R. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03701-0 · Cited by 26
Lasko, M. J., Gethers, M. L., Tabor-Rennie, J. L., Nicolau, D. P., & Kuti, J. L. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02167-21 · Cited by 26
Fratoni, A. J., Nicolau, D. P., & Kuti, J. L. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac018 · Cited by 26
Gaibani, P., Amadesi, S., Lazzarotto, T., & Ambretti, S. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.06.021 · Cited by 26
Lima, O., Sousa, A., Longueira-Suárez, R., Filgueira, A., Taboada-Martínez, C., Portela-Pino, C., Nodar, A., Vidal, F. J. V., Martínez-Lamas, L., Pérez‐Landeiro, A., et al. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04482-9 · Cited by 26
Lodise, T. P., O’Donnell, J. N., Raja, S. M., Guptill, J. T., Zaharoff, S., Schwager, N., Fowler, V. G., Beresnev, T. H., Wall, A., Wiegand, K., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00935-22 · Cited by 26
Lee, S. Y., Gill, C. M., Nicolau, D. P., ERACE-PA Global Study Group, Aktaş, E., Alfouzan, W. A., Bourassa, L. A., Brink, A. J., Burnham, C. D., Cantón, R., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad225 · Cited by 26
Self-citationClinical outcomes using minocycline for Stenotrophomonas maltophilia infections
Jacobson, S., Noa, L. J., Wallace, M. R., & Bowman, M. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw327 · Cited by 25
Zhou, M., Yang, Q., Lomovskaya, O., Sun, D., Kudinha, T., Xu, Z., Zhang, G., Chen, X., & Xu, Y. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky251 · Cited by 25
Phillips, M. C., Wald‐Dickler, N., Loomis, K. J., Luna, B. M., & Spellberg, B. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa460 · Cited by 25
Karaba, S. M., Goodman, K. E., Amoah, J., Cosgrove, S. E., & Tamma, P. D. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00793-21 · Cited by 25
Self-citationCoyne, A. J. K., Ghali, A. E., Lucas, K., Witucki, P., Rebold, N., Holger, D. J., Veve, M. P., & Rybak, M. J. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad034 · Cited by 25
Wang, C.-C., Chao, T.-Y., Chen, Y., Fang, W., Kao, H., Chen, H., Tsai, Y.-C., Shen, L.-S., Li, C.-L., Chang, H., et al. (2014) · Biomedical Journal · doi:10.4103/2319-4170.132879 · Cited by 24
Taşbakan, M. S., Pullukçu, H., Sipahf, O., Taşbakan, M., Aydemir, Ş., & Bacakoğlu, F. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.6.345 · Cited by 24
Dizbay, M., Özger, H. S., Karaşahin, Ö., & Karaşahin, E. F. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1506-157 · Cited by 24
Fox, M. T., Melia, M. T., Same, R. G., Conley, A. T., & Tamma, P. D. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.01.025 · Cited by 24
Self-citationRobin, F., Auzou, M., Bonnet, R., Lebreuilly, R., Isnard, C., Cattoir, V., & Guérin, F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00675-18 · Cited by 24
Biagi, M. J., Butler, D. A., Tan, X., Qasmieh, S., & Wenzler, E. (2019) · Antibiotics · doi:10.3390/antibiotics8010027 · Cited by 24
In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017–2018
Dong, D., Zheng, Y., Chen, Q., Guo, Y. P., Yang, Y., Wu, S., Zhu, D., Deng, D., Bradford, P. A., Reinhart, H. H., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03877-w · Cited by 24
Chou, A., Welch, E., Hunter, A. S., & Trautner, B. W. (2022) · Drugs · doi:10.1007/s40265-022-01676-5 · Cited by 24
Lodise, T. P., O’Donnell, J. N., Balevic, S. J., Liu, X., Gu, K., George, J. M., Raja, S. M., Guptill, J. T., Zaharoff, S., Schwager, N., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00936-22 · Cited by 24
Pfaller, M. A., Shortridge, D., Sader, H. S., Flamm, R. K., & Castanheira, M. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.05.025 · Cited by 23
Karlowsky, J. A., Lob, S. H., Young, K., Motyl, M. R., & Sahm, D. F. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.001 · Cited by 23
Sader, H. S., Mendes, R. E., Kimbrough, J. H., Kantro, V., & Castanheira, M. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad058 · Cited by 23
Characterization of Indole-Positive Proteus mirabilis
Matsen, J. M., Blazevic, D. J., Ryan, J. A., & Ewing, W. H. (1972) · Applied Microbiology · doi:10.1128/am.23.3.592-594.1972 · Cited by 22
Qin, J., Huang, H., Zhou, H., Zhu, Y., Xu, Y., & Du, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-86342-8 · Cited by 22
Stewart, A. G., Harris, P. N. A., Chatfield, M. D., Littleford, R. C., & Paterson, D. L. (2021) · Trials · doi:10.1186/s13063-021-05206-8 · Cited by 22
Gill, C. M., Abdelraouf, K., Oota, M., Nakamura, R., Kuroiwa, M., Gahara, Y., Takemura, M., Yamano, Y., & Nicolau, D. P. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab221 · Cited by 22
Hoellinger, B., Kaeuffer, C., Boyer, P., Lefèbvre, N., Hansmann, Y., Robert, A., Séverac, F., Gravet, A., Danion, F., Ruch, Y., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.07.004 · Cited by 22
Dao, B. D., Barreto, J. N., Wolf, R. C., Dierkhising, R., Plevak, M. F., & Tosh, P. K. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.08.003 · Cited by 21
Giamarellos‐Bourboulis, E. J., Karnesis, L., Galani, I., & Giamarellou, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3997-3999.2002 · Cited by 21
Smith, K. P., Brennan-Krohn, T., Weir, S. K., & Kirby, J. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02128-16 · Cited by 21
Kulengowski, B., & Burgess, D. S. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz040 · Cited by 21
Karlowsky, J. A., Lob, S. H., Young, K., Motyl, M. R., & Sahm, D. F. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa056 · Cited by 21
In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii
Noel, A., Attwood, M., Bowker, K. E., & MacGowan, A. P. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa508 · Cited by 21
CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales
Mathers, A. J., & Lewis, J. S. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab020 · Cited by 21
Self-citationZhang, H., Jia, P., Zhu, Y., Zhang, G., Zhang, J., Kang, W., Duan, S., Zhang, W., Yang, Q., & Xu, Y. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s325520 · Cited by 21
Fratoni, A. J., Kuti, J. L., & Nicolau, D. P. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106395 · Cited by 21
Zha, L., Zhang, D., Pan, L., Ren, Z., Li, X., Zou, Y., Li, S., Luo, S., Yang, G., & Tefsen, B. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00516-5 · Cited by 21
Sader, H. S., Castanheira, M., Flamm, R. K., Huband, M. D., & Jones, R. N. (2016) · Surgical Infections · doi:10.1089/sur.2016.036 · Cited by 20
Morrisette, T., Alosaimy, S., Lagnf, A. M., Frens, J. J., Webb, A. J., Veve, M. P., Stevens, R. W., Bouchard, J. L., Gore, T. W., Ansari, I., et al. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00645-5 · Cited by 20
Lu, B., Wong, M., Ha, D. R., Bounthavong, M., Banaei, N., Deresinski, S. C., & Diep, C. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad037 · Cited by 20
Senchyna, F., Murugesan, K., Rotunno, W., Nadimpalli, S. S., Deresinski, S. C., & Banaei, N. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad759 · Cited by 20
The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia
Ekren, P. K., Töreyin, Z. N., Sayıner, A., & Bacakoğlu, F. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001539 · Cited by 19
Nasir, N., Ahmed, S., Razi, S., Awan, S., & Mahmood, S. F. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4648-7 · Cited by 19
Carrié, C., Bardonneau, G., Petit, L., Ouattara, A., Gruson, D., Pereira, B., & Biais, M. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.11.005 · Cited by 19
Derrick, C., Bookstaver, P. B., Lu, K., Bland, C. M., King, S. T., Stover, K. R., Rumley, K. F., MacVane, S. H., Swindler, J., Kincaid, S. E., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9050254 · Cited by 19
Self-citationChabert, P., Provoost, J., Cohen, S., Dupieux, C., Bitker, L., Ferry, T., Goutelle, S., & Richard, J. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01059-9 · Cited by 19
Lai, J.-J., Siu, L.-K. K., Chang, F., Lin, J., Yu, C.-M., Wu, R., & Wang, C.-H. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.03.001 · Cited by 19
Dahyot, S., & Mammeri, H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05630-11 · Cited by 18
Fernández-Cuenca, F., Tomás, M., Caballero-Moyano, F. J., Bou, G., Pascual, Á., Vilanova, A., Benítez, A. B., Montiel, N., Calleja, A. I. L., Guerra, L. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx464 · Cited by 18
Jean, S., Hsieh, T.-C., Lee, W., Hsueh, P., Hsu, C.-W., & Lam, C. (2018) · Medicine · doi:10.1097/md.0000000000012278 · Cited by 18
Negri, M.-C., & Baquero, F. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00721.x · Cited by 18
Karlowsky, J. A., Walkty, A. J., Baxter, M. R., Adam, H. J., Lagacé-Wiens, P. R. S., Schweizer, F., Bay, D. C., Lynch, J. P., Mulvey, M. R., & Zhanel, G. G. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01724-22 · Cited by 18
Esterly, J. S., Qi, C., Malczynski, M., & Scheetz, M. H. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.4.354 · Cited by 17
Baek, J. H., Kim, C. O., Jeong, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Yong, D., Song, Y. G., Lee, K., & Kim, J. M. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.987 · Cited by 17
Lee, Y., Wang, Y.-C., Kuo, S., Chen, C.-T., Liu, C.-P., Liu, Y.-M., Chen, T.-L., & Yang, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00931-17 · Cited by 17
Akata, K., Muratani, T., Yatera, K., Naito, K., Noguchi, S., Yamasaki, K., Kawanami, T., Kido, T., & Mukae, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218589 · Cited by 17
Diarra, A., Pascal, L. B., Carpentier, B., Baclet, N., Cabaret, P., Georgel, A., Dubreuil, L. J., & Weyrich, P. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2021.01.014 · Cited by 17
Holger, D. J., Rebold, N., Alosaimy, S., Morrisette, T., Lagnf, A. M., Belza, A. C., Coyne, A. J. K., Ghali, A. E., Veve, M. P., & Rybak, M. J. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00687-9 · Cited by 17
Hakeam, H. A., Askar, G., Sulaiman, K. A. A., Mansour, R., AlQahtani, M. M., Abbara, D., Aldhayyan, N., Dyab, N., Afaneh, L., Islami, M., et al. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.08.020 · Cited by 17
Asempa, T. E., Kois, A. K., Gill, C. M., & Nicolau, D. P. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac425 · Cited by 17
Campbell, J. D., Lewis, J. S., McElmeel, M. L., Fulcher, L. C., & Jorgensen, J. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06248-11 · Cited by 16
Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by Avibactam
Nukaga, M., Papp‐Wallace, K. M., Hoshino, T., Lefurgy, S. T., Bethel, C. R., Barnes, M. D., Zeiser, E. T., Johnson, J. K., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02371-17 · Cited by 16
Self-citationSader, H. S., Mendes, R. E., Arends, S. J. R., Carvalhaes, C. G., & Castanheira, M. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04400-z · Cited by 16
Biagi, M. J., Lee, M., Wu, T., Shajee, A., Patel, S., Deshpande, L. M., Mendes, R. E., & Wenzler, E. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115674 · Cited by 16
Cai, T., Tamanini, I., Mattevi, D., Verze, P., Palmieri, A., MALOSSINI, G., Mirone, V. G., Novelli, A., Tascini, C., & Johansen, T. E. B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105935 · Cited by 15
Elbaz, M., & Ben‐Ami, R. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa369 · Cited by 15
Caffrey, A. R., Appaneal, H. J., Liao, J. X., Piehl, E. C., Lopes, V., Dillon, R. J., Puzniak, L., & LaPlante, K. L. (2022) · Antibiotics · doi:10.3390/antibiotics11050626 · Cited by 15
Mounier, R., Guen, R. L., Woerther, P., Nacher, M., Bonnefon, C., Mongardon, N., Langeron, O., Levesque, É., Couffin, S., Houcke, S., et al. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01079-5 · Cited by 15
Koirala, A., Krishnappa, B., Banh, C., Brandenburg, U., Findlay, M., & Williams, P. C. M. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004051 · Cited by 15
Soto, C. L., Hsu, A. J., Lee, J. H., Dzintars, K., Choudhury, R., Jenkins, T. C., McCreary, E. K., Quartuccio, K. S., Stohs, E. J., Zimmerman, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad476 · Cited by 15
Self-citationHevia, E. C., Wooten, L., & Carr, A. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231201850 · Cited by 15
Pfaller, M. A., Shortridge, D., Carvalhaes, C. G., & Castanheira, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01981-23 · Cited by 15
Liu, C., Wang, X., Chen, Y., Hao, H., Li, X., Liang, J., Duan, R., Li, C., Zhang, J., Shao, S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01282 · Cited by 13
Meini, S., Laureano, R., Tascini, C., Arena, F., Fani, L., Frullini, A., Passaleva, M. T., Roberts, A. T., Mannini, D., Sbrana, F., et al. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.014 · Cited by 13
Drozdinsky, G., Neuberger, A., Rakedzon, S., Nelgas, O., Cohen, Y., Rudich, N., Mushinsky, L., Ben‐Zvi, H., Paul, M., & Yahav, D. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0234 · Cited by 13
Gill, C. M., Aktaş, E., Alfouzan, W. A., Bourassa, L. A., Brink, A. J., Burnham, C. D., Cantón, R., Carmeli, Y., Falcone, M., Kiffer, C. R. V., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-21 · Cited by 13
Stefano, A. F. D. D., Radicioni, M. M., Morano, F., Gentili, A., Mallat, E., Cuomo, D., Mazzarella, T., & Fonzo, V. D. (2022) · Antibiotics · doi:10.3390/antibiotics11111458 · Cited by 13
Zappulo, E., Grimaldi, F., Paolillo, R., Pinchera, B., Buonomo, A. R., Picardi, M., Catania, M. R., Pane, F., & Gentile, I. (2022) · Annals of Hematology · doi:10.1007/s00277-022-05006-3 · Cited by 13
Teo, J. Q.-M., Chang, H. Y., Tan, S. H., Tang, C. Y., Ong, R. T., Ko, K. K. K., Chung, S. J., Tan, T. T., & Kwa, A. L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01002-23 · Cited by 13
Hareza, D. A., Cosgrove, S. E., Simner, P. J., Harris, A. D., Bergman, Y., Conzemius, R., Jacobs, E. B., Beisken, S., & Tamma, P. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad703 · Cited by 13
Self-citationEliopoulos, G. M. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_a.37 · Cited by 12
Zaidenstein, R., Miller, A., Tal-Jasper, R., Ofer-Friedman, H., Sklarz, M. Y., Katz, D. E., Lazarovitch, T., Lephart, P., Mengesha, B., Tzuman, O., et al. (2018) · Microorganisms · doi:10.3390/microorganisms6010009 · Cited by 12
Ferreira, T. D. C., & Martins, I. S. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s312920 · Cited by 12
Longshaw, C. M., ECHOLS, R. M., Henriksen, A. S., Baba, T., Nguyen, S., & Yamano, Y. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01100-22 · Cited by 12
Torres, N. D. A., Morales, R., Lopes, L. F. B., Zeigler, R., & Uip, D. É. (2023) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17290 · Cited by 12
Lazarus, J. E., Wang, Y., Waldor, M. K., & Hooper, D. C. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-23 · Cited by 12
Widmer, A. F., Kern, W. V., Roth, J. A., Dettenkofer, M., Götting, T., Bertz, H., & Theilacker, C. (2019) · Infection · doi:10.1007/s15010-019-01327-0 · Cited by 11
Imoto, W., Kaneko, Y., Yamada, K., Kuwabara, G., Yamairi, K., Shibata, W., Oshima, K., Niki, M., Nakaie, K., Watanabe, T., et al. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.10.024 · Cited by 11
Walkty, A. J., Karlowsky, J. A., Baxter, M. R., Adam, H. J., Golden, A., Lagacé-Wiens, P. R. S., & Zhanel, G. G. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115418 · Cited by 11
Adámková, V., Mareković, I., Szabó, J., Pojnar, Ł., Billová, S., Herceg, S. H., Kuraieva, A., & Możejko-Pastewka, B. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04452-1 · Cited by 11
Branton, A. C., Vu, C., Venugopalan, V., Santevecchi, B. A., Cherabuddi, K., Ramphal, R., Manohar, T., & DeSear, K. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad021 · Cited by 11
Dequidt, T., Bastian, S., Nacher, M., Breurec, S., Carles, M., Thiéry, G., Camous, L., Tressières, B., Valette, M., & Pommier, J. (2023) · Critical Care · doi:10.1186/s13054-023-04712-2 · Cited by 11
Sader, H. S., Castanheira, M., Jones, R. N., & Flamm, R. K. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.11.019 · Cited by 10
Stewart, A. G., Cottrell, K., Henderson, A., Vemuri, K. R., Bauer, M. J., Paterson, D. L., & Harris, P. N. A. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00226-21 · Cited by 10
Monogue, M. L., Heil, E. L., Aitken, S. L., & Pogue, J. M. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2623 · Cited by 10
Self-citationEmergence of Resistance in Klebsiella aerogenes to Piperacillin-Tazobactam and Ceftriaxone
Custodio, M. M., Sanchez, D., Anderson, B., Ryan, K. L., Walraven, C. J., & Mercier, R.-C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01038-20 · Cited by 9
Wilson, G., Fitzpatrick, M. A., Suda, K. J., Smith, B. M., González, B., Jones, M., Schweizer, M. L., Evans, M. E., & Evans, C. T. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac106 · Cited by 9
Mukerji, A. C., Sharma, M., Taneja, O. P., Saxena, S. N., Bhatnagar, R. K., & Ghosh-Ray, B. (2009) · Chemotherapy · doi:10.1159/000220613 · Cited by 8
Viana, G. F., Saalfeld, S. M. D. S., Moreira, R. R. B., Menegucci, T. C., Garcia, L. B., Cardoso, C. L., Carrara-Marroni, F. E., & Tognim, M. C. B. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.07.001 · Cited by 8
An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate
Thomson, G. K., Ayaz, M., Lutes, K., & Thomson, K. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01309-17 · Cited by 8
Peters, D. M., Winter, J., Droege, C. A., Ernst, N. E., & Liao, S. (2020) · Hospital Pharmacy · doi:10.1177/0018578720931463 · Cited by 8
Abouelhassan, Y., Nicolau, D. P., & Abdelraouf, K. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae229 · Cited by 8
Lob, S. H., Hackel, M., Young, K., Motyl, M. R., & Sahm, D. F. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115421 · Cited by 7
Horwich-Scholefield, S., Lloyd, T., Varghese, V., Yette, E., Huang, S., & Pandori, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02288-20 · Cited by 7
Machuca, I., Guzmán-Puche, J., Pérez‐Nadales, E., Gracia-Ahufinger, I., Mendez, A., Cano, Á., Castón, J. J., Domínguez, A., Torre‐Cisneros, J., & Martínez-Martínez, L. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.07.017 · Cited by 6
Minocycline in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae
Khatri, A. M., Lobo, S. A., Nog, R., Lee, L., Wang, G., & Dhand, A. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.221 · Cited by 5
Dosing of Ertapenem in an Extreme Obesity: A Case Report of 250 kg Patient
Lass, J., Tamme, K., Kipper, K., & Starkopf, J. (2017) · Case Reports in Critical Care · doi:10.1155/2017/5310768 · Cited by 4
Tsai, Y. V., Bookstaver, P. B., Kohn, J. E., Justo, J. A., Childress, D. T., Stramel, S., Slain, D., Tu, P. J., Wingler, M. J. B., Jones, B. M., et al. (2024) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2024.26 · Cited by 4
Self-citationTalan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A., Reuning-Scherer, J., & Church, D. A. (2000) · JAMA · doi:10.1001/jama.283.12.1583
Cited by
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Rahimbakhsh, A., Seyfahmadi, M., Souldozi, A., Hakimelahi, R., Alikhani, M. Y., & Kafilzadeh, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-23260-z · Cited by 1
Zhang, Y., Liao, G., Song, J., Liao, Y., & Zhang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1924203
Metadata
- Authors
- Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-08-07
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4401413536
- Cited by
- 1,191
- References
- 717
- FWCI
- 125.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.